Beyond the Molecule: a healthcare innovation podcast
13 October 2020
Subscribe to our newsletter
Introducing Beyond the Molecule – our brand-new podcast where we interview industry leaders to uncover the untold stories of healthcare innovation.
Subscribe to our newsletter
In this podcast, we talk to the healthcare leaders behind the industry’s top innovations, from scientists and drug developers to healthcare technology entrepreneurs. We cover their successes and discover how they developed their idea into a product or service that transforms patient outcomes.
How do you succeed in an industry where 90% of products fail? Our hosts Martin Brass and James Atherton talk to pioneers defying the odds and developing healthcare innovations that are changing the world. But we don’t just cover their successes. We deep dive into our guests’ failures, lessons learned, and map the moments that defined them.
Martin Brass: Head of Corporate Social Responsibility, Communications and Facilities
Martin has 20 years’ experience in healthcare innovation. In 2002 he co-founded our member agency Blue Latitude Health, calling on his extensive experience in digital technology to create an agency and consultancy with multichannel marketing at its core. He sold the company to Fishawack Health in 2018.
James Atherton: Managing Director, Blue Latitude Health, USA
James heads up our New York office. Over the years he has developed the strategic IP of our Consulting capability and has worked across a range of clients and project types; from business transformation for Pfizer and Boehringer Ingelheim, to brand and launch strategies for Janssen. He is particularly interested in how disruptive companies and technology are reshaping the environment for businesses and end customers.
#7 Leena Dalal – How do you launch a therapy for an ultra-rare disease?
In this special bonus episode, we deep dive into rare disease and reveal not one but two perspectives from specialists in this area. First Leena Dalal, Vice President, Brand Marketing at Alnylam tells the story behind ONPATTRO – a therapy that astounded doctors and patients with its ability to reverse the debilitating nerve damage caused by ultra-rare disease hATTR amyloidosis. Then, our Creative Director Kristin Morris, reveals what she learned in 11 years working solely in rare disease. She covers the changing landscape, how COVID-19 is impacting the patients, and her tips for ensuring authenticity in a virtual world.
#6 Sunny Kumar – How do you find and fund innovation?
Have you ever wondered how venture capitalists know which healthcare tech to invest in? Sunny Kumar Partner at GSR Ventures reveals how he differentiates between hype and true innovation, why he’s passionate about artificial intelligence and informatics, and what the future looks like for the healthcare tech industry in the aftermath of COVID-19.
Jill Hopkins has dedicated her life to restoring people’s vision. In this episode she talks about what it’s like to fight blindness, a game-changing innovation in ophthalmology, and how Roche-Genentech keeps innovating in the wake of COVID-19.
#4 Dr Steven Shak – How do you become a precision medicine pioneer?
What does it mean to truly innovate, not just once but many times over? Dr. Steven Shak may be one of the few people who can help answer this question; from discovering the DNase1 gene, to developing a life-altering treatment for cystic fibrosis, and guiding revolutionary cancer drug Herceptin from concept to clinic, Steve Shak’s groundbreaking work has changed the lives of millions across the globe. Now, in his newest venture as Chief Medical Officer at Exact Sciences, his portfolio of precision diagnostic tests have ensured one million cancer patients receive the right treatment at the right time. We discuss his life’s work (so far), his advice for pharma execs, and what next for the scientist.
#3 Dan Brillman and Taylor Justice – How do you unite health and social care?
In a country where health and social care are divided, Dan and Taylor have done the seemingly impossible. Inspired by their fellow veterans’ experiences, they developed Unite Us – a platform that connects communities, governments and healthcare systems around the single goal of improving health holistically. In this episode, they reveal how they’re achieving this vision, their journey from military veterans to CEOs, and their advice for start-ups operating in complex healthcare environments.
#2 Zoe Harris – How do you personalise care for dementia patients?
When her husband battled dementia and lost the ability to communicate, Zoe saw first-hand how the care team’s failure to understand his needs negatively impacted his outcomes. So, she took matters into her own hands. She developed a tool to personalise his care and now her solution – Mycarematters – is used by care staff and hospitals across the UK to improve the lives of cognitively impaired patients.
#1 Jacob Glanville – How do you treat rapidly mutating viruses?
Jacob Glanville has always been fascinated by the intersection of technology and medicine. Fuelled by his experiences growing up in war torn Guatemala, he wondered how he could use technology to create a post-pathogen humanity. Now, as CEO of Distributed Bio, he’s achieving this vision. In this episode, he explains the story behind his innovative universal vaccine tech, why he made the choice to leave a top job at a prestigious pharmaceutical company, and how he got to where he is today.
Take a sneak peek at our new podcast ‘Beyond the Molecule’ where we interview healthcare pioneers to reveal the untold stories of healthcare innovation. We learn about their personal stories, how they got to where they are today, and their successes and failures, to uncover their journey from initial idea to transformative innovation.